deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT05456529

Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

A Phase 3, Open-Label, One-Year Safety Study of Ruxolitinib Cream in Adolescents (Ages ≥ 12 Years to < 18 Years) With Atopic Dermatitis

Sponsor: Incyte Corporation

Interventions Ruxolitinib Cream
Updated 11 times since 2022 Last updated: Jun 6, 2025 Started: Sep 1, 2022 Primary completion: May 17, 2024 Completion: May 17, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Atopic Dermatitis (AD) and is currently completed. Incyte Corporation leads this study, which shows 11 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshotRecruiting~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshotRecruiting~Dec 2022 – ~Jun 2023 · 6 months · monthly snapshotRecruiting~Jun 2023 – ~Nov 2023 · 5 months · monthly snapshotActive Not Recruiting~Nov 2023 – ~May 2024 · 6 months · monthly snapshotActive Not Recruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotActive Not Recruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotCompleted~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotCompleted~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

11 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Jul 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Jul 2025 [monthly]

    Completed PHASE3

  4. Aug 2024 — Sep 2024 [monthly]

    Completed PHASE3

    Status: Active Not RecruitingCompleted

  5. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting PHASE3

Show 6 earlier versions
  1. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

  2. Nov 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE3

  3. Jun 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  4. Dec 2022 — Jun 2023 [monthly]

    Recruiting PHASE3

  5. Nov 2022 — Dec 2022 [monthly]

    Recruiting PHASE3

  6. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Incyte Corporation
Data source: Incyte Corporation

For direct contact, visit the study record on ClinicalTrials.gov .